Middle East & Africa Viscosupplementation Market Size & Outlook
Middle East & Africa viscosupplementation market, 2018-2030 (US$M)
Related Markets
MEA viscosupplementation market highlights
- The MEA viscosupplementation market generated a revenue of USD 70.9 million in 2023.
- The market is expected to grow at a CAGR of 9.3% from 2024 to 2030.
- In terms of segment, single injection was the largest revenue generating product in 2023.
- Single Injection is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Saudi Arabia is expected to register the highest CAGR from 2024 to 2030.
MEA data book summary
| Market revenue in 2023 | USD 70.9 million |
| Market revenue in 2030 | USD 132.6 million |
| Growth rate | 9.3% (CAGR from 2023 to 2030) |
| Largest segment | Single injection |
| Fastest growing segment | Single Injection |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Single Injection, Three Injection, Five Injection |
| Key market players worldwide | DePuy Synthes, Sanofi SA, Smith & Nephew PLC, Anika Therapeutics Inc, Zimmer Biomet Holdings Inc, Ferring, Lifecore Biomedical Inc, LG Chem, Roche Holding AG |
Other key industry trends
- In terms of revenue, MEA region accounted for 1.5% of the global viscosupplementation market in 2023.
- Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
- Europe is the fastest growing regional market and is projected to reach USD 1,284.7 million by 2030.
Single injection was the largest segment with a revenue share of 43.16% in 2023. Horizon Databook has segmented the Middle East & Africa viscosupplementation market based on single injection, three injection, five injection covering the revenue growth of each sub-segment from 2018 to 2030.
Westernization has led to increased prevalence of obesity in MEA, which eventually can be attributed to the rising number of osteoarthritis patients in the region. Rising concerns over the scenario of musculoskeletal disorders in the region may increase the demand for viscosupplements.
For instance, a division of the Emirati Medical Association (EMA) and the Emirates Osteoporosis Society (EOS) in association have contacted the government to raise awareness about osteoporosis treatment and prevention.
Moreover, increasing reimbursement policies in the region may further drive the viscosupplementation market in this region. For instance, the treatment of osteoporosis and DXA exams are reimbursed for UAE nationals. Although viscosupplements have not well-penetrated the region, the market is expected to grow at a steady pace over the forecast period.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Viscosupplementation Market Scope
Viscosupplementation Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
MEA viscosupplementation market size, by country, 2018-2030 (US$M)
Middle East & Africa Viscosupplementation Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
